Researcher Next
Create account
← Back to directory

Mustafa Özgüroğlu

Researcher Next ID · RN-009897

Researcher · Medicine

Istanbul University-Cerrahpaşa

, Turkey

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
552
Citation count
44,569
H-index
62
i10-index
184

Research interests

Medicine
Lung Cancer Research Studies
Cancer Immunotherapy and Biomarkers
Neuroendocrine Tumor Research Advances
Peptidase Inhibition and Analysis
Prostate Cancer Treatment and Research

Publications

  • Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

    The Lancet · 2019 · 10.1016/s0140-6736(19)32222-6

  • Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

    New England Journal of Medicine · 2018 · 10.1056/nejmoa1809697

  • Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

    New England Journal of Medicine · 2017 · 10.1056/nejmoa1709937

  • Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

    New England Journal of Medicine · 2017 · 10.1056/nejmoa1704174

  • Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

    The Lancet · 2010 · 10.1016/s0140-6736(10)61389-x

Current projects

    No projects listed.